PROFUND ADVISORS LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1129919 BETHESDA, MD

Position in KRYS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,144,535

-$126,097 QoQ

Shares Held

5,770

-34.4% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#158

of 416 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. KRYS ranks #7 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc. This page	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,144,535	5,770	-34.4%	Shares	Sole	2026-08-11
2026-03-31	$2,270,632	8,790	-11.1%	Shares	Sole	2026-04-27
2025-12-31	$2,437,540	9,887	+18.7%	Shares	Sole	2026-02-06
2025-09-30	$1,470,494	8,330	+2.0%	Shares	Sole	2025-11-06
2025-06-30	$1,122,498	8,166	+36.9%	Shares	Sole	2025-08-07
2025-03-31	$1,075,128	5,963	-5.7%	Shares	Sole	2025-05-08
2024-12-31	$990,247	6,321	-36.7%	Shares	Sole	2025-02-14
2024-09-30	$1,817,569	9,985	+14.9%	Shares	Sole	2024-11-14
2024-06-30	$1,596,382	8,693	+1.6%	Shares	Sole	2024-08-13
2024-03-31	$1,521,835	8,553	-37.9%	Shares	Sole	2024-05-08
2023-12-31	$1,709,794	13,782	+12.6%	Shares	Sole	2024-02-14
2023-09-30	$1,419,840	12,240	+24.1%	Shares	Sole	2023-11-13
2023-06-30	$1,158,151	9,865	-14.8%	Shares	Sole	2023-08-10
2023-03-31	$927,174	11,581	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.